e-learning
resources
Vienna 2012
Monday, 03.09.2012
Respiratory infections: prognosis and outcome
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prediction of prognosis in healthcare-associated pneumonia
I. Ito, T. Ishida, H. Tachibana, H. Tomioka, S. Kadowaki, N. Tanabe, M. Mishima (Kyoto, Kurashiki, Kobe, Ono, Japan)
Source:
Annual Congress 2012 - Respiratory infections: prognosis and outcome
Session:
Respiratory infections: prognosis and outcome
Session type:
Thematic Poster Session
Number:
2473
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Ito, T. Ishida, H. Tachibana, H. Tomioka, S. Kadowaki, N. Tanabe, M. Mishima (Kyoto, Kurashiki, Kobe, Ono, Japan). Prediction of prognosis in healthcare-associated pneumonia. Eur Respir J 2012; 40: Suppl. 56, 2473
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Prediction of complications development and lethal outcome in patients with community-acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Analysis of mortality from community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 376s
Year: 2006
Biomarkers as complication predictors in community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia
Source: Annual Congress 2012 - CT findings: educational posters
Year: 2012
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
Source: Eur Respir J 2004; 24: Suppl. 48, 548s
Year: 2004
Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 350s
Year: 2006
Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Thrombocytosis is a marker of poor outcome in community-acquired pneumonia
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
Epidemiology of community-acquired pneumonia and nosocomial pneumonia
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Comparison of the predictive performance of severity assessment tools in community-acquired or health care-associated pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016
Obesity is associated with improved outcome in community-acquired pneumonia
Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections
Year: 2012
Risk factors of paediatric community-acquired pneumonia
Source: Eur Respir J 2011; 37: 724-725
Year: 2011
Biomarkers and clinical stability in community-acquired pneumonia
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Biomarkers in severe community-acquired pneumonia (SCAP) prognosis, complications and outcomes
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 992-993
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept